Search results
Treatment is directed at alleviating organ dysfunction, preventing irreversible scarring, and improving quality of life. Herein, we review the indications for treatment, pharmacotherapy, treatment duration, side effects, adjunct non-pharmacologic therapies, and outcomes for patients.
When systemic treatment is recommended for sarcoidosis, oral GCs are the option of first choice. GCs are usually effective in treating granulomatous inflammation. The dose and duration of GC treatment should be chosen on a case-by-case basis, bearing in mind the high risk of relapses during tapering and the fact that long-term treatment periods ...
Updated British guidelines on interstitial lung disease, including sarcoidosis, were published in 2008. This review describes current management strategies for pulmonary disease, including oral and inhaled steroids, commonly used alternative immunosuppressant agents, and lung transplantation.
29 lis 2022 · How to Treat Pulmonary Sarcoidosis Induction and Maintenance Phases of Treatment. Most experts agree that short courses (e.g. a few weeks) of high-dose corticosteroids are less useful than a longer course of lower dose treatment (total of > 6 months) for long-term remission [12, 41, 42••].
Patients with sarcoidosis and precapillary pulmonary hypertension should be treated with therapies such as phosphodiesterase inhibitors and prostacyclin analogues.
Pulmonary sarcoidosis causes inflammation and tiny lumps called granulomas in the lungs. Many people with this condition get well on their own or feel better with short-term treatment. If you have trouble breathing, talk to a healthcare provider for diagnosis and treatment options.
1 lut 2020 · Abstract. Sarcoidosis is a multisystem granulomatous disease, associated with significant morbidity and impaired quality of life. Treatment is aimed at recovering organ function, reducing symptom burden and improving quality of life.
